RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
Ipsen
David R Spigel; Afshin Dowlati; Yuanbin Chen; Alejandro Navarro; James Chih-Hsin Yang; Goran Stojanovic; Maria Jove; Patricia Rich; Zoran G Andric; Yi-Long Wu; Charles M Rudin; Huanyu Chen; Li Zhang; Stanley Yeung; Fawzi Benzaghou; Luis Paz-Ares; Paul A Bunn; RESILIENT Trial Investigators